Additional Information
Size: |
100 µg |
Target: |
GABARAPL2 |
Conjugate: |
PerCP |
Research Area: |
Cell Signaling | Protein Trafficking | Vesicle Transport | Cancer | Autophagy | Cell Signaling | Metabolism | Metabolism processes |
Alternative Name: |
ATG8 Antibody, FLC3A Antibody, General protein transport factor p16 Antibody, GEF-2 Antibody, GABARAPL2 Antibody, GBRL2_HUMAN Antibody, GEF2 Antibody, GABA(A) receptor-associated protein-like 2 Antibody, MAP1 light chain 3-related protein Antibody, G |
Category: |
Antibodies |
Product Type: |
Polyclonal Antibody |
Immunogen: |
Synthetic peptide from the C-terminal of Human GABARAPL2 |
Immunogen Species: |
Human |
Applications: |
WB, ICC/IF |
Host: |
Rabbit |
Isotype: |
N/A |
Species Reactivity: |
Human, Rat |
Antibody Dilution: |
WB (1:1000), ICC/IF (1:100); optimal dilutions for assays should be determined by the user. |
Purification: |
Peptide Affinity Purified |
Storage Buffer: |
PBS, 50% glycerol, 0.09% sodium azide |
Concentration: |
1 mg/ml |
Specificity: |
Detects ~14 kDa. |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
Certificate of Analysis: |
A 1:1000 dilution of SPC-624 was sufficient for detection of GABARAPL2 in 15 µg of rat liver cell lysates by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody. |
Cellular Localization: |
Golgi Apparatus, Cytoplasmic Vesicle, Autophagosome |
Tissue Specificity: |
Ubiquitous. Expressed at high levels in the brain, heart, prostate, ovary, spleen and skeletal muscle. Expressed at very low levels in lung, thymus and small intestine. |
Accession Number: |
NP_009216.1 |
Gene ID: |
11345 |
Swiss-Prot: |
P60520 |
Field of Use: |
For in vitro research use only. |